Biotechnology Value Fund, L.P. is an evergreen fund specializing in early stage financing. It focuses on undervalued investment
Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments.Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its investments.BVF is committed to working with its portfolio companies as partners in their successes.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
Jul 13, 2021
Nimbus Therapeutics
|
Series Unknown | $105M | Biotechnology | Yes |
Jan 9, 2019
Black Diamond Therapeutics
|
Series B | $85M | Biotechnology | — |
Nov 13, 2017
Arcus Biosciences
|
Series C | $107M | Biotechnology | — |
Jan 7, 2014
Blueprint Medicines
|
Series B | $25M | Bioinformatics | — |